MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Smartphone applications in Parkinson’s disease: current data on disease monitoring, medication adherence, and movement modulation

    S. Tripathi, A. Malhotra, S. Barkan, C. Henchcliffe, H. Sarva (New York City, NY, USA)

    Objective: To review current literature of PD smartphone applications. Background: Smartphone applications show promise in management of several diseases. For PD patients these apps provide…
  • MDS Virtual Congress 2020

    CBIT Response in Clinical Practice: The Potential Importance of Comorbidities and Tic location

    S. Chiu, K. Au, W. Deeb, L. Almeida, H. Simpson, M. Okun, I. Malaty (Gainesville, FL, USA)

    Objective: 1) To evaluate whether comorbidities influence Comprehensive Behavioral Intervention for Tics (CBIT) response. 2) To evaluate the response of tic phenotypes and location to…
  • MDS Virtual Congress 2020

    Kinematic assessment of bradykinesia in essential tremor compared to Parkinson’s disease: a cluster analysis

    M. Bologna, G. Paparella, D. Colella, A. Cannavacciuolo, L. Angelini, D. Alunni-Fegatelli, A. Guerra, A. Berardelli (Rome, Italy)

    Objective: We aimed to evaluate the bradykinesia features in ET by clinical examination and kinematic analysis of repetitive finger movements. We compared data collected in…
  • MDS Virtual Congress 2020

    No frank biochemical evidence of proteinopathy in the cerebellar cortex of patients with essential tremor

    A. Rajput, A. Rajput, C. Tremblay, F. Calon, K. Melançon, E. Aubry-Lafontaine, E. Brochu, S. Paris-Robidas (Quebec, QC, Canada)

    Objective: This study was designed to determine the presence of common types of proteinopathies in the cerebellar cortex of patients who died with essential tremor…
  • MDS Virtual Congress 2020

    Attitudes towards disease in patients with essential tremor

    Y. Trufanov, N. Svyrydova, V. Sereda, V. Svistun, A. Yanchak, I. Zarashchak (Kyiv, Ukraine)

    Objective: The objective of our research was to study the types of attitude towards the disease in patients with essential tremor (ET). Background: The Personal…
  • MDS Virtual Congress 2020

    Parkinson’s Foundation Physical Therapy Faculty Program Evaluation

    M. Rafferty, L. Hoffman, L. King, T. Ellis, F. Horak (Chicago, IL, USA)

    Objective: In 2016, the Parkinson’s Foundation partnered with clinical and research experts to implement a training program for physical therapy (PT) faculty who want to…
  • MDS Virtual Congress 2020

    Upward Gaze Palsy in SCA3: a valuable semiological sign

    G. Franklin, F. Nascimento, A. Meira, C. Camargo, H. Teive (Curitiba, Brazil)

    Objective: Evaluate the prevalence of upward gaze palsy (UGP) and investigate its useful in assisting the clinical differentiation of SCAs. Background: Spinocerebellar ataxias (SCAs) represent…
  • MDS Virtual Congress 2020

    GAD65 antibody neurologic syndrome presenting with hemiparkinsonism

    R. Patel, N. Witek, P. Pinna, M. Afshari (Chicago, IL, USA)

    Objective: To describe a novel phenotype of glutamic acid decarboxylase-65 (GAD65) antibody-associated neurological disease in which an older patient initially presented with levodopa-unresponsive hemiparkinsonism and…
  • MDS Virtual Congress 2020

    Choreoathetosis post lentiform nucleus ischemic Stroke: A unique pathology and presentation

    A. Deep, B. Krishnaiah, M. Ishfaq, O. Saeed, S. Shah, S. Singh, A. Alexandrov (Memphis, TN, USA)

    Objective: To discuss a unique movement disorder as a complication of ischemic stroke involving the lenticular nucleus and its pharmacological management Background: Movement disorders after…
  • MDS Virtual Congress 2020

    Long-Term Treatment With Deutetrabenazine (DTBZ) Is Associated With Continued Improvement in Tardive Dyskinesia (TD): Results From the Completed, 3-year Open-Label Extension (OLE) Study

    R. Hauser, H. Barkay, H. Fernandez, S. Factor, J. Jimenez-Shahed, N. Gross, L. Marinelli, A. Wilhelm, M. Gordon, J.M Savola, K. Anderson (Tampa, FL, USA)

    Objective: To evaluate long-term efficacy and safety of DTBZ in patients with TD by examining change from baseline in Abnormal Involuntary Movement Scale (AIMS) scores…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley